...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Approaches for introducing peptides into intact and functional arteriolar smooth muscle: manipulation of protein kinase-based signalling.
【24h】

Approaches for introducing peptides into intact and functional arteriolar smooth muscle: manipulation of protein kinase-based signalling.

机译:将肽引入完整和功能性小动脉平滑肌的方法:基于蛋白激酶的信号传导的操纵。

获取原文
获取原文并翻译 | 示例

摘要

1. An exact understanding of signal transduction pathways within intact and functional arteriolar smooth muscle is made difficult by limited access to the intracellular environment due to the cell membrane. The aim of the present studies was to determine the feasibility of using polycationic lipids and reverse permeabilization for the introduction of peptide inhibitors into smooth muscle cells of the intact arteriolar wall. 2. Isolated cannulated arterioles were exposed to polycationic lipid preparations together with varying concentrations of the protein beta-galactosidase (30-90 microg/mL). Similar experiments were also performed using cultured smooth muscle cells. Staining for the chromogenic substrate of beta-galactosidase (5-bromo-4-chloro-3-indolyl-beta-d-galactosidase; X-gal) demonstrated incorporation of the protein into cultured cells but not intact arteriolar smooth muscle. Similarly, polycationic lipid treatment did not enable loading of arteriolar smooth muscle (as assessed by cAMP-mediatedvasodilation) with the protein kinase (PK) A inhibitory peptide PKI. 3. In contrast, reverse permeabilization, using high ATP concentrations in the presence of EGTA enabled introduction of PKI and inhibition of forskolin-mediated vasodilatation. Furthermore, arterioles maintained full viability following reverse permeabilization, as demonstrated by an ability to develop spontaneous myogenic tone. 4. Reverse permeabilization provides a method for introducing peptide inhibitors into functional arteriolar smooth muscle and manipulating signal transduction. Protein transfection using polycationic lipids appears to be limited by the barrier provided by the adventitia or inherent differences between cells under cultured conditions compared within the intact arteriole.
机译:1.由于细胞膜限制进入细胞内环境,很难准确了解完整和功能性小动脉平滑肌内的信号转导途径。本研究的目的是确定使用聚阳离子脂质和反向通透性将肽抑制剂引入完整小动脉壁平滑肌细胞的可行性。 2.将分离的空心小动脉与不同浓度的蛋白质β-半乳糖苷酶(30-90 microg / mL)一起暴露于聚阳离子脂质制剂中。使用培养的平滑肌细胞也进行了类似的实验。对β-半乳糖苷酶(5-溴-4-氯-3-吲哚基-β-d-半乳糖苷酶; X-gal)的生色底物进行染色显示,该蛋白已掺入培养的细胞中,但未整合完整的小动脉平滑肌。类似地,聚阳离子脂质治疗无法使蛋白激酶(PK)A抑制肽PKI加载小动脉平滑肌(通过cAMP介导的血管舒张评估)。 3.相反,在EGTA存在下使用高ATP浓度进行反向透化,可以引入PKI并抑制福司柯林介导的血管舒张。此外,小动脉在反向通透后仍保持完整的生存能力,这由发展自发性肌源性音调的能力证明。 4.反向通透性提供了一种将肽抑制剂引入功能性小动脉平滑肌并操纵信号转导的方法。使用聚阳离子脂质的蛋白质转染似乎受到外膜提供的屏障或完整小动脉内培养条件下细胞之间固有差异的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号